These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 9212825
1. Co-localization of endogenous and exogenous p53 proteins in nasopharyngeal carcinoma cells. Hwang JK, Lin CT. J Histochem Cytochem; 1997 Jul; 45(7):991-1003. PubMed ID: 9212825 [Abstract] [Full Text] [Related]
2. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F. Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971 [Abstract] [Full Text] [Related]
3. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors. Lin SR, Yang YC, Jung JH, Tsai JH. DNA Cell Biol; 1996 Oct 01; 15(10):793-803. PubMed ID: 8892752 [Abstract] [Full Text] [Related]
4. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Spruck CH, Tsai YC, Huang DP, Yang AS, Rideout WM, Gonzalez-Zulueta M, Choi P, Lo KW, Yu MC, Jones PA. Cancer Res; 1992 Sep 01; 52(17):4787-90. PubMed ID: 1511442 [Abstract] [Full Text] [Related]
5. Mutations of the p53 gene in human functional adrenal neoplasms. Lin SR, Lee YJ, Tsai JH. J Clin Endocrinol Metab; 1994 Feb 01; 78(2):483-91. PubMed ID: 8106638 [Abstract] [Full Text] [Related]
6. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Goldman SC, Chen CY, Lansing TJ, Gilmer TM, Kastan MB. Am J Pathol; 1996 May 01; 148(5):1381-5. PubMed ID: 8623910 [Abstract] [Full Text] [Related]
8. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. Keleti J, Quezado MM, Abaza MM, Raffeld M, Tsokos M. Am J Pathol; 1996 Jul 01; 149(1):143-51. PubMed ID: 8686737 [Abstract] [Full Text] [Related]
9. Identification of p53 gene mutations in breast cancers and their effects on transcriptional activation function. Oh SJ, Jung JY, Shim SS, Im MY, Kim HD, Chung SY, Yoon JH. Mol Cells; 2000 Jun 30; 10(3):275-80. PubMed ID: 10901165 [Abstract] [Full Text] [Related]
10. Mutational analysis of p53 and RB2/p130 genes in Malaysian nasopharyngeal carcinoma samples: a preliminary report. Hoe SL, Sam CK. Malays J Pathol; 2006 Jun 30; 28(1):35-9. PubMed ID: 17694957 [Abstract] [Full Text] [Related]
11. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708 [Abstract] [Full Text] [Related]
12. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL, Koeffler HP. Oncogene; 1994 Jul 15; 9(7):1899-906. PubMed ID: 8208536 [Abstract] [Full Text] [Related]
13. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]. Wang H, Lai B, Li J. Zhonghua Jie He He Hu Xi Za Zhi; 1998 May 15; 21(5):268-72. PubMed ID: 11326947 [Abstract] [Full Text] [Related]
15. [The expression of tumor suppressor gene p53 and Rb gene in nasopharyngeal carcinoma]. Song Y, Wang L, Huang G, Huang R, Yuan S, Liu Y. Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep 15; 28(3):268-71. PubMed ID: 10684031 [Abstract] [Full Text] [Related]
16. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation. Wang Y, Yamaguchi Y, Watanabe H, Ohtsubo K, Wakabayashi T, Sawabu N. J Gastroenterol; 2002 Sep 15; 37(10):831-9. PubMed ID: 12424567 [Abstract] [Full Text] [Related]
17. Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues. Iwaya K, Tsuda H, Fujita S, Suzuki M, Hirohashi S. Lab Invest; 1995 Jun 15; 72(6):707-14. PubMed ID: 7540234 [Abstract] [Full Text] [Related]
18. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. Jossart GH, Epstein HD, Shaver JK, Weier HU, Greulich KM, Tezelman S, Grossman RF, Siperstein AE, Duh QY, Clark OH. J Clin Endocrinol Metab; 1996 Oct 15; 81(10):3498-504. PubMed ID: 8855792 [Abstract] [Full Text] [Related]
19. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Bonsing BA, Corver WE, Gorsira MC, van Vliet M, Oud PS, Cornelisse CJ, Fleuren GJ. Cytometry; 1997 May 01; 28(1):11-24. PubMed ID: 9136751 [Abstract] [Full Text] [Related]
20. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells. Chang FL, Ling YF, Lai MD. Anticancer Res; 2000 May 01; 20(1A):329-36. PubMed ID: 10769676 [Abstract] [Full Text] [Related] Page: [Next] [New Search]